Sodium cromoglycate and provocation tests in chronic urticaria. 1982

C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi

Twenty patients with chronic urticaria exacerbated by aspirin or tartrazine were challenged with the offending substance after pre-treatment with either oral sodium cromoglycate or placebo in a double-blind, crossover study. The sequential vascular response test (SVR) described by Fisherman and Cohen 1-4 was used to assess response to challenge. Eighteen patients were protected by oral sodium cromoglycate and one by placebo, taking as a positive response an increase in the bleeding time of 100% or more over control values.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013645 Tartrazine An anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics, and as a biological stain. FD & C Yellow No. 5,FD&C Yellow No. 5,Tartrazine Barium,Tartrazine Barium (2:3),Barium, Tartrazine

Related Publications

C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
March 1980, Allergy,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
October 1978, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
January 1990, Allergy,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
March 1973, Therapeutique (La Semaine des hopitaux),
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
January 1976, Medicina cutanea ibero-latino-americana,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
March 1974, Clinical allergy,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
January 1981, Acta dermato-venereologica,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
July 1993, Annals of allergy,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
January 1975, Dermatologica,
C Ortolani, and U Cornelli, and M Bellani, and E Pastorello, and C Zanussi
February 1976, British medical journal,
Copied contents to your clipboard!